Browse our anti-Activity-Dependent Neuroprotector Homeobox (ADNP) Antibodies

Full name:
anti-Activity-Dependent Neuroprotector Homeobox Antibodies (ADNP)
On are 96 Activity-Dependent Neuroprotector Homeobox (ADNP) Antibodies from 21 different suppliers available. Additionally we are shipping Activity-Dependent Neuroprotector Homeobox Kits (10) and Activity-Dependent Neuroprotector Homeobox Proteins (4) and many more products for this protein. A total of 114 Activity-Dependent Neuroprotector Homeobox products are currently listed.
AA589558, ADNP1, mKIAA0784
list all antibodies Gene Name GeneID UniProt
ADNP 11538  
ADNP 23394 Q9H2P0
ADNP 64622  

Show all species

Show all synonyms

Most Popular Reactivities for anti-Activity-Dependent Neuroprotector Homeobox (ADNP) Antibodies

Select your species and application

anti-Mouse (Murine) Antibodies:

anti-Human Antibodies:

anti-Rat (Rattus) Antibodies:

All available anti-Activity-Dependent Neuroprotector Homeobox Antibodies

Go to our pre-filtered search.

Top referenced anti-Activity-Dependent Neuroprotector Homeobox Antibodies

  1. Cow (Bovine) Polyclonal ADNP Primary Antibody for WB - ABIN2780972 : Mandel, Gozes: Activity-dependent neuroprotective protein constitutes a novel element in the SWI/SNF chromatin remodeling complex. in The Journal of biological chemistry 2007 (PubMed)

  2. Human Polyclonal ADNP Primary Antibody for ICC, IF - ABIN258198 : Cattano, Valleggi, Ma, Kastsiuchenka, Abramo, Sun, Cavazzana, Natale, Maze, Giunta: Xenon induces transcription of ADNP in neonatal rat brain. in Neuroscience letters 2008 (PubMed)

  3. Human Polyclonal ADNP Primary Antibody for IF (p), IHC (p) - ABIN724040 : Ma, Chu, Zhang, Jiang, Jia, Dang, Gao: Intranasal Delivery of Recombinant NT4-NAP/AAV Exerts Potential Antidepressant Effect. in Neurochemical research 2016 (PubMed)

  4. Human Polyclonal ADNP Primary Antibody for ELISA, WB - ABIN1534122 : Deloukas, Matthews, Ashurst, Burton, Gilbert, Jones, Stavrides, Almeida, Babbage, Bagguley, Bailey, Barlow, Bates, Beard, Beare, Beasley, Bird, Blakey, Bridgeman, Brown, Buck, Burrill, Butler, Carder et al.: The DNA sequence and comparative analysis of human chromosome 20. ... in Nature 2002 (PubMed)

More Antibodies against Activity-Dependent Neuroprotector Homeobox Interaction Partners

Mouse (Murine) Activity-Dependent Neuroprotector Homeobox (ADNP) interaction partners

  1. Hippocampal ADNP expression was greater in males than in females. Haploinsufficiency led to increased hippocampal eIF4E and ApoE expression.

  2. the newly identified shared microtubule target of NAP (show CTNNBL1 Antibodies)/ADNP is directly implicated in synaptic plasticity, explaining the breadth and efficiency of neuroprotective/neurotrophic capacities

  3. ADNP expression is increased in the cerebral cortex of a transgenic mouse model of Alzheimer disease.

  4. NAP (show CTNNBL1 Antibodies) is an ADNP derived peptide that modulates the tubulin (show TUBB Antibodies) pool in mice and rats

  5. Results support the hypothesis that ADNP expression is related to early or mild Alzheimer's disease progression by a VIP (show Vip Antibodies)-independent mechanism.

  6. ADNP is identified as a new key gene essential for organogenesis in the developing embryo and may be implicated as a clinical target associated with proper neurodevelopment.

  7. ADNP has a part in the estrus cycle as an affecter or an effector.

  8. The mRNA transcripts for activity-dependent neuroprotective protein (ADNP, the NAP (show CTNNBL1 Antibodies) containing protein) were shown to increase 29 days post closed head injury in the injured hemisphere of Mac-1 (show ITGAM Antibodies) expressing mice.

  9. ADNP expression is mediated through multiple receptors and signaling pathways that are regulated by different concentrations of PACAP (show ADCYAP1 Antibodies)

  10. results place ADNP at a crucial point of gene regulation, repressing potential endoderm genes and enhancing genes associated with organogenesis/neurogenesis

Human Activity-Dependent Neuroprotector Homeobox (ADNP) interaction partners

  1. The study identified intratumoral heterogeneity (ITH) of the ADNP mutations in colorectal cancers, suggesting that ADNP mutations occurred during tumor progression rather than as an early event. The generation of ITH may influence on clinical outcome of the cancer patients.

  2. These findings demonstrate that the down-regulation of protein ADNP is an early pathological alteration and may contribute to dopaminergic neurodegeneration in Parkinson's disease

  3. This review covers the myriad of important ADNP-protein interactions and glimpse at their potential meaning in autism, schizophrenia and Alzheimer's disease. [review]

  4. ADNP expression was increased in male hippocampus samples compared to female samples.

  5. Mutations in the ADNP gene cause syndromic autism.Ample evidence exists that ADNP is of key importance for proper functioning of the nBAF complex.

  6. This study showed ADNP that deregulated in postmortem hippocampal samples from schizophrenia patients, but that now showed a significantly increased expression in lymphocytes from related patients.

  7. Ten patients with autism spectrum disorders and other shared clinical characteristics, including intellectual disability and facial dysmorphisms caused by a mutation in ADNP, a transcription factor involved in the SWI (show SMARCA1 Antibodies)/SNF (show SNRPA Antibodies) remodeling complex.

  8. Chromatin immunoprecipitation demonstrates the ability of ADNP to bind to its own promoter, consistent with its action as a repressor of both promoter-supported and endogenous ADNP expression.

  9. Our results suggested that ADNP may play an important role in slowing the progression of clinical symptoms of AD.

  10. In the prefrontal cortex of schizophrenia patients the correlation between ADNP and ADNP2 (show ADNP2 Antibodies) mRNA levels was apparently higher than in the hippocampus (r=0.854, p<0.001), but did not reach a significant difference (p=0.25).

Activity-Dependent Neuroprotector Homeobox (ADNP) Antigen Profile

Antigen Summary

Vasoactive intestinal peptide is a neuroprotective factor that has a stimulatory effect on the growth of some tumor cells and an inhibitory effect on others. This gene encodes a protein that is upregulated by vasoactive intestinal peptide and may be involved in its stimulatory effect on certain tumor cells. The encoded protein contains one homeobox and nine zinc finger domains, suggesting that it functions as a transcription factor. This gene is also upregulated in normal proliferative tissues. Finally, the encoded protein may increase the viability of certain cell types through modulation of p53 activity. Alternatively spliced transcript variants encoding the same protein have been described.

Alternative names and synonyms associated with Activity-Dependent Neuroprotector Homeobox (ADNP)

  • activity-dependent neuroprotective protein (Adnp) antibody
  • activity-dependent neuroprotector homeobox (ADNP) antibody
  • activity-dependent neuroprotector homeobox (Adnp) antibody
  • AA589558 antibody
  • ADNP1 antibody
  • mKIAA0784 antibody

Protein level used designations for ADNP

activity-dependent neuroprotector homeobox protein , ADNP homeobox 1 , activity-dependent neuroprotective protein , NAP peptide

11538 Mus musculus
23394 Homo sapiens
419350 Gallus gallus
485927 Canis lupus familiaris
100141411 Sus scrofa
533757 Bos taurus
64622 Rattus norvegicus
Selected quality suppliers for anti-Activity-Dependent Neuroprotector Homeobox (ADNP) Antibodies
Did you look for something else?